GlobeImmune, Inc. (GBIM)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Feb 13, 2026
GlobeImmune Market Cap
GlobeImmune has a market cap or net worth of $6 as of March 9, 2026. Its market cap has decreased by -100.00% in one year.
Market Cap
6.00
Enterprise Value
n/a
Revenue
6.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since July 2, 2014, GlobeImmune's market cap has decreased from 60.99M to 6.00, a decrease of -100.00%. That is a compound annual growth rate of -75.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 6.00 | -98.96% |
| Dec 31, 2025 | 575.00 | 9,483.33% |
| Dec 12, 2024 | 6.00 | -99.85% |
| Dec 30, 2022 | 4.03K | 600.17% |
| Dec 31, 2021 | 575.00 | -99.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TetraLogic Pharmaceuticals | 24.00 |
| Verde Science | 24.00 |
| Sienna Biopharmaceuticals | 23.00 |
| Kiromic BioPharma | 16.00 |
| IMV Inc. | 15.00 |
| 9 Meters Biopharma | 14.00 |
| PhaseRx | 12.00 |
| ContraFect | 11.00 |